Literature DB >> 412587

Anaplastic seminoma.

M Kademian, A Bosch, W L Caldwell, W Jaeschke.   

Abstract

Eight patients with the diagnosis of anaplastic seminoma of the testicle were treated during the megavoltage era from January 1959 to January 1976. Two patients with Stage I disease and one patient with Stage IV disease have died from their malignancy. By contrast, 57 patients with typical seminoma were treated during the same interval and with the same treatment methods. However, only two patients with typical seminoma have died. One of these patients had Stage II disease and one had Stage IV disease. There were no deaths among patients with Stage I typical seminoma. These results suggest that anaplastic seminoma has a poorer prognosis than typical seminoma even when the diseases are compared stage for stage. Implications for therapy are discussed.

Entities:  

Mesh:

Year:  1977        PMID: 412587     DOI: 10.1002/1097-0142(197712)40:6<3082::aid-cncr2820400648>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Mediastinal type B3 thymoma combined with germ cell tumor: cytologic diagnosis.

Authors:  Xiang-Lan Zhu; Gan-Di Li; Jin-Nan Li; Yong Jiang; Wei-Ping Liu; Xue-Ying Su
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

2.  Testicular neoplasms: seminoma.

Authors:  E K Reddy; M Burke; S Giri; L Krishnan; L Gemer; R Evans; W K Mebust; J Wiegel
Journal:  J Natl Med Assoc       Date:  1990-09       Impact factor: 1.798

3.  Mitotic count in seminomas--an unreliable criterion for distinguishing between classical and anaplastic types.

Authors:  A R von Hochstetter
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

4.  Anaplastic variant of classical seminoma of the testis: northern Israel oncology center experience and brief review of literature.

Authors:  Moshe E Stein; Jamal Zidan; Tomer Charas; Karen Drumea; Rahamim Ben-Yosef
Journal:  Rambam Maimonides Med J       Date:  2014-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.